Ardent Health Partners, Inc. (ARDT)vsMerck & Company Inc (MRK)
ARDT
Ardent Health Partners, Inc.
$9.76
+1.35%
HEALTHCARE · Cap: $1.38B
MRK
Merck & Company Inc
$109.18
-1.60%
HEALTHCARE · Cap: $274.03B
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 928% more annual revenue ($65.01B vs $6.32B). MRK leads profitability with a 28.1% profit margin vs 2.1%. ARDT trades at a lower P/E of 10.0x. MRK earns a higher WallStSmart Score of 59/100 (C).
ARDT
Hold43
out of 100
Grade: D
MRK
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for ARDT.
Margin of Safety
-13.2%
Fair Value
$96.48
Current Price
$109.18
$12.70 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Reasonable price relative to book value
Mega-cap, among the largest globally
Every $100 of equity generates 37 in profit
Strong operational efficiency at 32.8%
Keeps 28 of every $100 in revenue as profit
Attractively priced relative to earnings
Generating 1.8B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
2.1% margin — thin
Elevated debt levels
Revenue declined 0.1%
Weak financial health signals
Expensive relative to growth rate
Earnings declined 19.3%
Comparative Analysis Report
WallStSmart ResearchBull Case : ARDT
The strongest argument for ARDT centers on P/E Ratio, Price/Book.
Bull Case : MRK
The strongest argument for MRK centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 28.1% and operating margin at 32.8%.
Bear Case : ARDT
The primary concerns for ARDT are Market Cap, Profit Margin, Debt/Equity. Debt-to-equity of 1.84 is elevated, increasing financial risk. Thin 2.1% margins leave little buffer for downturns.
Bear Case : MRK
The primary concerns for MRK are Piotroski F-Score, PEG Ratio, EPS Growth.
Key Dynamics to Monitor
MRK is growing revenue faster at 5.0% — sustainability is the question.
MRK generates stronger free cash flow (1.8B), providing more financial flexibility.
Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MRK scores higher overall (59/100 vs 43/100), backed by strong 28.1% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Ardent Health Partners, Inc.
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Ardent Health Partners, Inc., headquartered in Nashville, Tennessee, is a premier healthcare organization focused on delivering high-quality, patient-centered care through a comprehensive network of hospitals and outpatient facilities. Renowned for its extensive portfolio of acute care hospitals, Ardent is dedicated to innovating healthcare solutions that meet the diverse and evolving needs of communities. With a solid financial structure and a strategic vision for growth, the company is well-positioned to enhance access to healthcare and improve patient outcomes in a complex and dynamic industry landscape.
Visit Website →Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?